In human CRC cells, it functionally opposes the effects of Src and Yes by dephosphorylating both pY232 and pY291, switching Fas from the antiapoptotic state to the proapoptotic/anti-proliferative state (Figure 1C) (27). The gene discussed is YES1; the disease is colorectal carcinoma.